Innovative Trials

Innovative Trials

Advances in data and technology have opened the door to innovative clinical trial designs that are more convenient for patients, can drive faster development, and provide more personalized treatments. These designs embrace approaches like predicting outcomes through simulation models; deploying master protocols that enable the simultaneous investigation of multiple therapies; leveraging digital health technologies and novel endpoints; registry trials; trials embedded in clinical practice that utilize existing data and infrastructure; and many others.  

While innovative trial designs offer transformative potential to accelerate the development of new treatments for patients, knowing how and when to use them is critical. Use CTTI’s comprehensive suite of recommendations and resources to evaluate and deploy these designs, anticipate different logistics, navigate regulatory complexity, and support internal change management. 

Topic Resources

Regulatory Submissions + Approvals | Webinars

CTTI’s Disease Progression Modeling Recommendations & Tool Launch

Webinar Launching Disease Progression Modeling Recommendations and Framework

Regulatory Submissions + Approvals | CTTI News

CTTI Releases New Recommendations to Guide Use of Disease Progression Modeling in Medical Product Development

CTTI today released new recommendations to support the effective use of disease progression modeling (DPM) in medical product development.

Regulatory Submissions + Approvals | Resources

DPM Considerations Framework

Disease Progression Modeling Considerations Framework

Regulatory Submissions + Approvals | Recommendations

CTTI Recommendations: Disease Progression Modeling

These recommendations aim to highlight the unique benefits of using disease progression modeling in medical product development, when it should be considered over other tools or approaches, and provide considerations...

Innovative Trials | CTTI News

CTTI to Launch New Recommendations on Disease Progression Modeling in Free Public Webinar

CTTI will host a free public webinar on Tuesday, July 8, to introduce new recommendations for using disease progression modeling (DPM) to improve medical product development.

Safety

Antibacterial Drug Development

Increasing bacterial resistance coupled with decreasing research on new antibacterial drugs is creating a crisis that could disproportionately impact our most vulnerable populations, including children and the seriously ill. CTTI...

Innovative Trials | Expert Meetings

Optimizing Data Quality and Flexibility in Clinical Trials Expert Meeting

View materials from February 26, 2025 expert meeting

Site Planning | CTTI News

CTTI Leads Discussion on Digital Health Trials at ETH Digital Biomarkers Summit

In November 2024, Lindsay Kehoe, senior project manager at CTTI, presented at the Digital Biomarkers Summit held at ETH Zurich.

Site Planning | CTTI News

New Publication Shares Findings & Recommendations for Embedding Clinical Trial Elements into Routine Clinical Practice

A new CTTI publication published in the Journal of Clinical and Translational Science highlights the qualitative research findings that informed recommendations to facilitate the integration of clinical trials into clinical practice.

Innovative Trials

Optimizing Data Quality and Flexibility in Clinical Trials

CTTI’s project, Optimizing Data Quality and Flexibility in Clinical Trials, aims to enhance patient and site access, improve participant satisfaction, and facilitate the use of real-world data through flexible operational...

DHT sub topics

Formats

CTTI Project

Stage of Trial